Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis
| Image |  |
|---|---|
| Description | scientific article published on 21 December 2018 |
| Author/s |
author: Kojiro Michitaka Norio Itokawa Noritomo Shimada Akemi Tsutsui Real-life Practice Experts for HCC (RELPEC) Study Group, HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan) Hidenori Toyoda Yoichi Hiasa Hironori Ochi Atsushi Hiraoka Kouji Joko Kazuto Tajiri Koichi Takaguchi Michitaka Imai Toru Ishikawa Masanori Atsukawa Masashi Hirooka Toshifumi Tada Kazuhiro Nouso Takashi Kumada Kazuya Kariyama |
| Publication date | December 21, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |